we present the results of a prospective randomised trial of estradurin , a long-acting oestrogen preparation ( polyoestradiol phosphate ) , 160 mg per month , compared with bilateral orchiectomy in patients with advanced prostatic carcinoma ( t3m1 ; t4mo/m1 ) .
C0687716
estradurin
C0071554
polyoestradiol phosphate